Starling Oncology annual operating expenses
2020
2021
2022
2023
2024
2025
Starling Oncology Operating Expenses Growth & History (STLN)
Starling Oncology's operating expenses was $538.8M for fiscal 2025.
View full Starling Oncology company overviewStarling Oncology annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $538.8M | $85.3M | +18.80% |
| 2024 | 2024-12-31 | $453.5M | $52.3M | +13.03% |
| 2023 | 2023-12-31 | $401.3M | $66.8M | +19.98% |
| 2022 | 2022-12-31 | $334.4M | $85.6M | +34.39% |
| 2021 | 2021-12-31 | $248.9M | $53.1M | +27.16% |
| 2020 | 2020-12-31 | $195.7M | — | — |
Starling Oncology quarterly operating expenses
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $165.9M | $34.9M | +26.63% |
| Q1 2026 | 2026-03-31 | $154.0M | $39.6M | +34.67% |
| Q4 2025 | 2025-12-31 | $148.9M | $36.7M | +32.68% |
| Q3 2025 | 2025-09-30 | $144.6M | $30.9M | +27.13% |
| Q2 2025 | 2025-06-30 | $131.0M | $16.1M | +13.98% |
| Q1 2025 | 2025-03-31 | $114.3M | $1.7M | +1.49% |
| Q4 2024 | 2024-12-31 | $112.2M | $11.1M | +11.00% |
| Q3 2024 | 2024-09-30 | $113.8M | $17.8M | +18.54% |
| Q2 2024 | 2024-06-30 | $114.9M | $19.8M | +20.79% |
| Q1 2024 | 2024-03-31 | $112.6M | $3.6M | +3.28% |
| Q4 2023 | 2023-12-31 | $101.1M | $4.6M | +4.74% |
| Q3 2023 | 2023-09-30 | $96.0M | $10.9M | +12.80% |
| Q2 2023 | 2023-06-30 | $95.2M | $15.9M | +20.12% |
| Q1 2023 | 2023-03-31 | $109.1M | $35.4M | +48.11% |
| Q4 2022 | 2022-12-31 | $96.5M | $3.4M | +3.62% |
| Q3 2022 | 2022-09-30 | $85.1M | $30.6M | +56.29% |
| Q2 2022 | 2022-06-30 | $79.2M | $28.3M | +55.47% |
| Q1 2022 | 2022-03-31 | $73.6M | $23.3M | +46.29% |
| Q4 2021 | 2021-12-31 | $93.1M | — | — |
| Q3 2021 | 2021-09-30 | $54.4M | — | — |
| Q2 2021 | 2021-06-30 | $51.0M | — | — |
| Q1 2021 | 2021-03-31 | $50.3M | — | — |
Starling Oncology operating expenses trends
Over the last five fiscal years, Starling Oncology's operating expenses increased from $195.7M to $538.8M, a change of $343.1M. The latest reported quarter, Q2 2026, shows $165.9M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Starling Oncology source filings ↗